Chi Sheng Chemical (4111) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chi Sheng Chemical (4111) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$17.35 Million ≈ $546.49K USD) by net assets (NT$1.29 Billion ≈ $40.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Chi Sheng Chemical for the company's overall valuation and market capitalisation.
Chi Sheng Chemical - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Chi Sheng Chemical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chi Sheng Chemical ranked by their cash flow conversion efficiency. Explore how high is Chi Sheng Chemical's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IS:DGATE
|
2.440x |
|
Regis Corporation Common Stock
NYSE:RGS
|
0.009x |
|
Inspirato Inc
NASDAQ:ISPO
|
0.016x |
|
PP Properti Tbk PT
JK:PPRO
|
0.001x |
|
Integrated Logistics Bhd
KLSE:5614
|
-0.254x |
|
Remed Co.Ltd
KQ:302550
|
0.006x |
|
Daewon Media Co. Ltd
KQ:048910
|
0.095x |
|
GP Global Power Ltd
TA:GPGB
|
-0.052x |
Annual Cash Flow Conversion Efficiency for Chi Sheng Chemical (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024. View today's stock price for Chi Sheng Chemical for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$213.20 Million ≈ $6.72 Million |
0.167x | +173.64% |
| 2023-12-31 | NT$1.22 Billion ≈ $38.41 Million |
NT$74.52 Million ≈ $2.35 Million |
0.061x | -65.23% |
| 2022-12-31 | NT$1.22 Billion ≈ $38.50 Million |
NT$214.86 Million ≈ $6.77 Million |
0.176x | +38.89% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.68 Million |
NT$139.33 Million ≈ $4.39 Million |
0.127x | -5.13% |
| 2020-12-31 | NT$1.08 Billion ≈ $33.89 Million |
NT$143.53 Million ≈ $4.52 Million |
0.133x | -12.25% |
| 2019-12-31 | NT$1.07 Billion ≈ $33.77 Million |
NT$162.96 Million ≈ $5.13 Million |
0.152x | +39.15% |
| 2018-12-31 | NT$1.05 Billion ≈ $32.93 Million |
NT$114.19 Million ≈ $3.60 Million |
0.109x | -36.45% |
| 2017-12-31 | NT$1.05 Billion ≈ $33.19 Million |
NT$181.14 Million ≈ $5.71 Million |
0.172x | -- |
About Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more